Colgate-Palmolive (India) Ltd (NSE:COLPAL)
₹ 1,889 -21 (-1.1%) Market Cap: 514.04 Bil Enterprise Value: 500.25 Bil PE Ratio: 38.14 PB Ratio: 32.45 GF Score: 97/100

Q4 2026 Colgate-Palmolive (India) Ltd Earnings Call Transcript

May 22, 2026 / 12:00PM GMT
Release Date Price: ₹2156.9 (-0.37%)

Key Points

Positve
  • Colgate-Palmolive (India) Ltd (BOM:500830) reported a significant acceleration in net sales growth in Q4, with domestic growth at 9.2%.
  • The company's margin profile remains resilient, with gross margins at 69.6% and EBITDA margins over 32%, which are considered best-in-class.
  • There has been a substantial increase in brand investment, with a 10% rise compared to the previous year, indicating a strong focus on advertising and premiumization.
  • The premium portfolio has shown strong growth, with a 35% increase in contribution over the past two years, driven by successful products like Colgate Total and Visible White.
  • The company has made significant strides in sustainability, achieving 100% recyclable tubes and increasing renewable energy usage to 60%.
Negative
  • Overall year growth is flat due to tough quarters in the previous calendar year, impacting profitability.
  • The company faces challenges from commodity and currency headwinds, which could impact margins.
  • The GST inverted duty structure has resulted in an 80 basis points impact on margins for the full year.
  • Despite strong brand investments, the overall market remains flat to increasing, with rural growth slowing down.
  • There is increased competition in the premium segment, with competitors launching similar products, which could impact market share.
Operator

(audio in progress) I now hand over the proceedings to Ms. Neethi Nair, Director, Commercial Finance and Investor Relations at Colgate-Palmolive India Limited. Thank you, and over to you, ma'am.

Neethi Nair;India;Ltd;Director;Prabha Narasimhan
Colgate-Palmolive;Commercial Finance, Investor Relations and M&A;

()- -

Thank you, Pooja. Hello, everyone and welcome to the Colgate-Palmolive India analyst meet for the year ended March 31, 2026. We have today with us, Ms. Prabha Narasimhan, MD and CEO of the oragnization; and Mr. M.S. Jacob, CFO. We will start our session with a brief presentation from Prabha and Jacob. This would take approximately 40 minutes, and then we will open up for Q&A.

Before we start, I would like to point out that some of the statements made in today's meeting may be forward-looking and a disclaimer to that effect has been included in the presentation. I would now request Prabha to share her thoughts. Thank you, and over to you, Prabha.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot